GLAXF GSK plc

NEUTRAL Impact: 2/10 6-K
Horizon immediate Filed May 20, 2026 Processed 25d 18h ago SEC 0001654954-26-005164
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
GLAXF ▼ -0.51% at T+5d
NEUTRAL call ✗ call lost -0.51% · α vs SPY -1.74% · entry $25.70 → $25.57
Next anchor: T+20d in 3d
Last close $26.63 (close Jun 12) · +3.62% from $25.70 entry
Entry anchored
May 20, 2026
via day open
T+1d
+1.17%
call +1.17% · α +0.97%
$26.00
settled 25d ago
T+5d
-0.51%
call -0.51% · α -1.74%
$25.57
settled 18d ago
T+20d
call — · α —
in 3d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

GSK filed a 6-K reporting a routine director shareholding notification: Non-Executive Director Dr. Hal Barron acquired 74 ADS at $49.67 each via dividend reinvestment in his 401(k) plan, totaling approximately $3,676. This is an automatic, non-discretionary transaction of immaterial size and carries no signal about company outlook.

Actionable Insight

No actionable trading signal. This is a routine dividend reinvestment by a director. Monitor upcoming quarterly earnings and pipeline updates for material developments.

Key Facts

  • Dr. Hal Barron (Non-Executive Director) acquired 74 ADS at $49.6700 per share on May 15, 2026.
  • The acquisition was through dividend reinvestment within his GSK 401(k) plan account.
  • Total transaction value is approximately $3,676.
  • The filing is a routine PDMR transaction notification with no material financial implications.

Financial Impact

Trivial — $3,676 total value, less than 0.0001% of GSK's market cap.

Risk Factors

  • The filing has no inherent risk; unrelated risks include regulatory actions on GSK's product pipeline or patent litigation.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-005164
Document: 0001654954-26-005164-index-headers.html0001654954-26-005164
Document: 0001654954-26-005164-index.html0001654954-26-005164
Document: 0001654954-26-005164.txt0001654954-26-005164
51 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 10, 2026
4d ago
6-K
NEUTRAL ★ 1/10
$23.54 awaiting T+5awaiting T+5$26.63 (+13.13%)
Jun 9, 2026
5d ago
6-K
NEUTRAL ★ 1/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 9, 2026
5d ago
6-K
BULLISH ★ 7/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 1, 2026
13d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
Jun 1, 2026
13d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
May 28, 2026
17d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.63 (+8.34%)
May 27, 2026
18d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.63 (+4.15%)
May 26, 2026
19d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 26, 2026
19d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 22, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.63 (+2.42%)
Showing 10 of 51

US Market Status

Market Closed — Opens in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access